Pershing Square Holdings, Ltd. Announces Investor Call to Discuss its Investment in Valeant Pharmaceuticals International, Inc.
AMSTERDAM--(BUSINESS WIRE)--
Regulatory News:
Pershing Square Holdings, Ltd. (ticker: PSH:NA) will host a conference call for investors on 30 October 2015 at 9:00 EDT (13:00 GMT) to discuss PSH’s investment in Valeant Pharmaceuticals International. During the call, Bill Ackman and other members of the Pershing Square investment team will address questions from investors e‐mailed to [email protected].
A live audio webcast of the conference call will be available to the public on PSH's website at www.pershingsquareholdings.com. The conference call will also be available by phone. Dial‐in information and a link to the live audio webcast will be available at www.pershingsquareholdings.com on 29 October, 2015. Following the call, an audio replay will be available for two weeks until 13 November 2015 at midnight EST (14 November 2015 at 4:00 GMT). To access the audio webcast, please visit www.pershingsquareholdings.com.
About Pershing Square Holdings, Ltd.
Pershing Square Holdings, Ltd. (PSH:NA) is an investment holding company structured as a closed end fund that makes concentrated investments principally in North American companies.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151027005690/en/
Media:
StockWell Communications
Tim Burt, +44 (0)20
7240 2486
[email protected]
Source: Pershing Square Holdings, Ltd.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pershing Square Holdings, Ltd. Releases Regular Weekly Net Asset Value and Year-To-Date Return As Of 16 April 2024
- Illinois Speaker Chris Welch Recommended by Proviso Township Democratic Organization to Serve as Committeeman
- Vaxxinity Issues Shareholder Letter
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
William Ackman, Pershing Square CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!